BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 17049816)

  • 1. RBANS neuropsychological profiles within schizophrenia samples recruited from non-clinical settings.
    Loughland CM; Lewin TJ; Carr VJ; Sheedy J; Harris AW
    Schizophr Res; 2007 Jan; 89(1-3):232-42. PubMed ID: 17049816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia, II: convergent/discriminant validity and diagnostic group comparisons.
    Hobart MP; Goldberg R; Bartko JJ; Gold JM
    Am J Psychiatry; 1999 Dec; 156(12):1951-7. PubMed ID: 10588410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Test-retest stability of the Repeatable Battery for the Assessment of Neuropsychological Status in schizophrenia.
    Wilk CM; Gold JM; Bartko JJ; Dickerson F; Fenton WS; Knable M; Randolph C; Buchanan RW
    Am J Psychiatry; 2002 May; 159(5):838-44. PubMed ID: 11986139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative psychometric properties of the BACS and RBANS in patients with schizophrenia and schizoaffective disorder.
    Chianetta JM; Lefebvre M; LeBlanc R; Grignon S
    Schizophr Res; 2008 Oct; 105(1-3):86-94. PubMed ID: 18790606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia I: sensitivity, reliability, and validity.
    Gold JM; Queern C; Iannone VN; Buchanan RW
    Am J Psychiatry; 1999 Dec; 156(12):1944-50. PubMed ID: 10588409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of cognitive impairment with the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) in adolescents with psychotic symptomatology.
    Holzer L; Chinet L; Jaugey L; Plancherel B; Sofia C; Halfon O; Randolph C
    Schizophr Res; 2007 Sep; 95(1-3):48-53. PubMed ID: 17629676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) to investigate group and gender differences in schizophrenia and bipolar disorder.
    Gogos A; Joshua N; Rossell SL
    Aust N Z J Psychiatry; 2010 Mar; 44(3):220-9. PubMed ID: 20050718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brief cognitive assessment in schizophrenia: normative data for the Repeatable Battery for the Assessment of Neuropsychological Status.
    Wilk CM; Gold JM; Humber K; Dickerson F; Fenton WS; Buchanan RW
    Schizophr Res; 2004 Oct; 70(2-3):175-86. PubMed ID: 15329294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening of Cognitive Impairment in Schizophrenia: Reliability, Sensitivity, and Specificity of the Repeatable Battery for the Assessment of Neuropsychological Status in a Spanish Sample.
    De la Torre GG; Perez MJ; Ramallo MA; Randolph C; González-Villegas MB
    Assessment; 2016 Apr; 23(2):221-31. PubMed ID: 25934161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender differences in cognitive function of patients with chronic schizophrenia.
    Han M; Huang XF; Chen DC; Xiu MH; Hui L; Liu H; Kosten TR; Zhang XY
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):358-63. PubMed ID: 22820676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive functioning in schizophrenia and bipolar disorder: comparison of performance on the Repeatable Battery for the Assessment of Neuropsychological Status.
    Dickerson F; Boronow JJ; Stallings C; Origoni AE; Cole SK; Yolken RH
    Psychiatry Res; 2004 Nov; 129(1):45-53. PubMed ID: 15572184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of the Audio Recorded Cognitive Screen and its relation to functioning in schizophrenia.
    Gelder BM; Loughland CM; Carr VJ; Schofield PW
    Acta Neuropsychiatr; 2015 Oct; 27(5):279-90. PubMed ID: 25959604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of neuropsychological effort test performance in schizophrenia.
    Morra LF; Gold JM; Sullivan SK; Strauss GP
    Schizophr Res; 2015 Mar; 162(1-3):205-10. PubMed ID: 25583248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spanish version of the Screen for Cognitive Impairment in Psychiatry (SCIP-S): psychometric properties of a brief scale for cognitive evaluation in schizophrenia.
    Pino O; Guilera G; Rojo JE; Gómez-Benito J; Bernardo M; Crespo-Facorro B; Cuesta MJ; Franco M; Martinez-Aran A; Segarra N; Tabarés-Seisdedos R; Vieta E; Purdon SE; Díez T; Rejas J;
    Schizophr Res; 2008 Feb; 99(1-3):139-48. PubMed ID: 17959358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are schizophrenia and schizoaffective disorder neuropsychologically distinguishable?
    Heinrichs RW; Ammari N; McDermid Vaz S; Miles AA
    Schizophr Res; 2008 Feb; 99(1-3):149-54. PubMed ID: 18031992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropsychological function and dysfunction in schizophrenia and psychotic affective disorders.
    Reichenberg A; Harvey PD; Bowie CR; Mojtabai R; Rabinowitz J; Heaton RK; Bromet E
    Schizophr Bull; 2009 Sep; 35(5):1022-9. PubMed ID: 18495643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A brief neurocognitive assessment of patients with psychosis following traumatic brain injury (PFTBI): Use of the Repeatable battery for the Assessment of Neuropsychological Status (RBANS).
    Batty RA; Francis A; Thomas N; Hopwood M; Ponsford J; Rossell SL
    Psychiatry Res; 2016 Mar; 237():27-36. PubMed ID: 26921048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interpretation of the RBANS in inpatient psychiatry: clinical normative data and prevalence of low scores for patients with schizophrenia.
    Iverson GL; Brooks BL; Haley GM
    Appl Neuropsychol; 2009; 16(1):31-41. PubMed ID: 19205946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A longitudinal study of cognitive functioning in schizophrenia: clinical and biological predictors.
    Dickerson F; Schroeder J; Stallings C; Origoni A; Katsafanas E; Schwienfurth LA; Savage CL; Khushalani S; Yolken R
    Schizophr Res; 2014 Jul; 156(2-3):248-53. PubMed ID: 24827555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.